Early surgical or transcatheter aortic valve replacement is not typically recommended for severe aortic stenosis in the ...

If an S3 heart sound is present, then significant systolic dysfunction has developed, which is common in end-stage aortic stenosis. Perhaps the best bedside method to estimate the severity of ...

Interestingly, diabetes, hypertension, hypercholesterolemia, and end-stage renal disease have all been shown to be risk factors for the development of aortic stenosis, leading to speculation that ...

If an S3 heart sound is present, significant systolic dysfunction has developed; this is common in end-stage aortic stenosis. To assess for parvus, it is often helpful to palpate one’s own ...

DAVID MONTGOMERY: Aortic stenosis is a tightening of one of the four major valves of the heart. The aortic valve is particularly important because the aortic valve is the gateway to the rest of ...

The phase II data are promising for patients who are managed with watchful waiting before being offered an intervention.

A: People with aortic stenosis are often diagnosed in the way ... Rather, the calcium is a late-stage manifestation of disordered metabolism within the valve leaflets. If not done already, your ...

As people age, a buildup of calcium on the aortic valve can make it thicker and stiffer leading to aortic stenosis.

Medtronic has announced the SMART trial’s two-year outcomes of Evolut TAVR for aortic stenosis (AS) and small aortic annulus.

Beyond that, the findings point to an intriguing opportunity: a ‘2 for 1’ medical therapy trial in patients with earlier stage aortic stenosis, namely one that targets both the valve and the ...

Medtronic released positive two-year trial Evolut TAVR results that demonstrated superior valve performance in small aortic ...